Global Methicillin-Resistant Staphylococcus aureus (MRSA) Testing Market Overview
Western Market Research estimates that the Global MRSA Testing Market was valued at USD XXXX million in 2025 and is projected to reach USD XXXX million by 2036, expanding at a CAGR of XX% during the forecast period 2026–2036.
MRSA testing plays a critical role in infection prevention, antimicrobial stewardship, and patient safety, particularly within hospitals and long-term care settings. Rapid and accurate identification of MRSA colonization or infection enables timely isolation, targeted therapy, and reduced transmission. Market growth is driven by the rising incidence of healthcare-associated infections (HAIs), expansion of screening programs, adoption of molecular diagnostics, and increasing regulatory emphasis on infection control.
This study integrates primary research (clinical microbiologists, infection-control teams, diagnostic manufacturers) with secondary analysis (guidelines, regulatory frameworks, historical utilization). The assessment evaluates test accuracy, turnaround time, automation, reimbursement dynamics, and regional adoption.
Impact of COVID-19 on the MRSA Testing Market
The pandemic disrupted routine screening in early phases but ultimately reinforced the importance of infection surveillance. Key impacts included:
-
Heightened awareness of nosocomial infection control
-
Increased investment in rapid and molecular diagnostics
-
Recovery of screening volumes alongside expanded ICU capacity
Post-pandemic, sustained focus on infection prevention has supported long-term demand.
Global MRSA Testing Market Segmentation
By Test Method
-
Molecular Diagnostics (PCR-based assays)
-
Immunodiagnostics
-
Culture-Based & Blood Testing
-
Others
By Sample Type
-
Nasal & Skin Swabs
-
Blood Samples
-
Wound & Tissue Samples
By Turnaround Time
-
Rapid / Point-of-Care Tests
-
Laboratory-Based Tests
By Application
-
Hospitals
-
Clinics
-
Diagnostic & Reference Laboratories
-
Long-Term Care & Others
Regional Analysis
North America
-
Strong regulatory mandates for MRSA screening
-
High adoption of PCR-based rapid tests
-
Mature reimbursement and laboratory automation
Europe
-
Widespread hospital surveillance programs
-
Increasing use of molecular diagnostics
-
Emphasis on antimicrobial stewardship
Asia-Pacific
-
Fastest-growing regional market
-
Rising HAI burden and expanding diagnostic infrastructure
-
Growing adoption of cost-effective rapid tests
South America
-
Gradual uptake supported by public health initiatives
-
Expansion of private diagnostic laboratories
Middle East & Africa
-
Growth driven by tertiary hospitals and infection-control modernization
-
Increasing access to molecular platforms
Competitive Landscape – Key Market Players
Competition is driven by test sensitivity, speed, automation compatibility, and regulatory approvals. Key players include:
-
Roche
-
BD
-
Bio-Rad
-
bioMérieux
-
Abbott
-
Danaher
-
Hain Lifescience
-
Abacus Diagnostica
-
Eurofins
-
Luminex
-
Puritan Medical
-
Arlington Scientific
Porter’s Five Forces Analysis
-
Threat of New Entrants: Medium – regulatory validation and clinical evidence required
-
Bargaining Power of Suppliers: Moderate – reagents and consumables
-
Bargaining Power of Buyers: High – hospitals and labs negotiate on volume and price
-
Threat of Substitutes: Moderate – culture methods vs molecular tests
-
Competitive Rivalry: High – innovation in speed and accuracy is critical
SWOT Analysis
Strengths
-
Essential for infection control and patient safety
-
Strong regulatory and guideline support
-
Growing adoption of rapid diagnostics
Weaknesses
-
Cost constraints in resource-limited settings
-
Need for trained laboratory personnel
Opportunities
-
Expansion of point-of-care MRSA testing
-
Integration with automated lab workflows
-
Emerging markets surveillance programs
Threats
-
Pricing pressure from healthcare payers
-
Competition from broad multiplex panels
Trend Analysis
-
Shift toward rapid PCR-based MRSA assays
-
Growth of screening programs in ICUs and surgical wards
-
Integration with laboratory automation systems
-
Increased focus on antimicrobial stewardship metrics
-
Adoption of multiplex infectious disease panels
Market Drivers & Challenges
Key Drivers
-
Rising incidence of healthcare-associated infections
-
Regulatory emphasis on infection prevention
-
Demand for rapid and accurate diagnostics
Key Challenges
-
Cost and reimbursement variability
-
Infrastructure gaps in developing regions
-
Competition from broader molecular panels
Value Chain Analysis
-
Reagent & Consumable Suppliers
-
Diagnostic Kit & Platform Manufacturers
-
Distributors & Laboratory Integrators
-
Hospitals & Diagnostic Centers
-
Clinicians & Infection-Control Teams
Strategic Recommendations for Stakeholders
-
Manufacturers: Invest in rapid, automated, and multiplex-ready MRSA assays
-
Hospitals: Implement routine screening in high-risk units
-
Investors: Target Asia-Pacific growth and point-of-care diagnostics
-
Labs: Adopt automation to reduce turnaround time
-
Policy Makers: Support reimbursement tied to HAI reduction outcomes
1. Market Overview of Methicillin-Resistant Staphylococcus Aureus Testing
1.1 Methicillin-Resistant Staphylococcus Aureus Testing Market Overview
1.1.1 Methicillin-Resistant Staphylococcus Aureus Testing Product Scope
1.1.2 Market Status and Outlook
1.2 Methicillin-Resistant Staphylococcus Aureus Testing Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Methicillin-Resistant Staphylococcus Aureus Testing Historic Market Size by Regions
1.4 Methicillin-Resistant Staphylococcus Aureus Testing Forecasted Market Size by Regions
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Methicillin-Resistant Staphylococcus Aureus Testing Sales Market by Type
2.1 Global Methicillin-Resistant Staphylococcus Aureus Testing Historic Market Size by Type
2.2 Global Methicillin-Resistant Staphylococcus Aureus Testing Forecasted Market Size by Type
2.3 Blood Testing
2.4 Immunodiagnostics
2.5 Others
3. Covid-19 Impact Methicillin-Resistant Staphylococcus Aureus Testing Sales Market by Application
3.1 Global Methicillin-Resistant Staphylococcus Aureus Testing Historic Market Size by Application
3.2 Global Methicillin-Resistant Staphylococcus Aureus Testing Forecasted Market Size by Application
3.3 Hospital
3.4 Clinic
3.5 Diagnostic Center
3.6 Others
3.7 Competitive Landscape:
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Methicillin-Resistant Staphylococcus Aureus Testing Production Capacity Market Share by Manufacturers
4.2 Global Methicillin-Resistant Staphylococcus Aureus Testing Revenue Market Share by Manufacturers
4.3 Global Methicillin-Resistant Staphylococcus Aureus Testing Average Price by Manufacturers
5. Company Profiles and Key Figures in Methicillin-Resistant Staphylococcus Aureus Testing Business
5.1 Roche
5.1.1 Roche Company Profile
5.1.2 Roche Methicillin-Resistant Staphylococcus Aureus Testing Product Specification
5.1.3 Roche Methicillin-Resistant Staphylococcus Aureus Testing Production Capacity, Revenue, Price and Gross Margin
5.2 BD
5.2.1 BD Company Profile
5.2.2 BD Methicillin-Resistant Staphylococcus Aureus Testing Product Specification
5.2.3 BD Methicillin-Resistant Staphylococcus Aureus Testing Production Capacity, Revenue, Price and Gross Margin
5.3 Bio-Rad
5.3.1 Bio-Rad Company Profile
5.3.2 Bio-Rad Methicillin-Resistant Staphylococcus Aureus Testing Product Specification
5.3.3 Bio-Rad Methicillin-Resistant Staphylococcus Aureus Testing Production Capacity, Revenue, Price and Gross Margin
5.4 Biomerieux
5.4.1 Biomerieux Company Profile
5.4.2 Biomerieux Methicillin-Resistant Staphylococcus Aureus Testing Product Specification
5.4.3 Biomerieux Methicillin-Resistant Staphylococcus Aureus Testing Production Capacity, Revenue, Price and Gross Margin
5.5 Abbott
5.5.1 Abbott Company Profile
5.5.2 Abbott Methicillin-Resistant Staphylococcus Aureus Testing Product Specification
5.5.3 Abbott Methicillin-Resistant Staphylococcus Aureus Testing Production Capacity, Revenue, Price and Gross Margin
5.6 Danaher
5.6.1 Danaher Company Profile
5.6.2 Danaher Methicillin-Resistant Staphylococcus Aureus Testing Product Specification
5.6.3 Danaher Methicillin-Resistant Staphylococcus Aureus Testing Production Capacity, Revenue, Price and Gross Margin
5.7 Hain Lifescience
5.7.1 Hain Lifescience Company Profile
5.7.2 Hain Lifescience Methicillin-Resistant Staphylococcus Aureus Testing Product Specification
5.7.3 Hain Lifescience Methicillin-Resistant Staphylococcus Aureus Testing Production Capacity, Revenue, Price and Gross Margin
5.8 Abacus Diagnostica
5.8.1 Abacus Diagnostica Company Profile
5.8.2 Abacus Diagnostica Methicillin-Resistant Staphylococcus Aureus Testing Product Specification
5.8.3 Abacus Diagnostica Methicillin-Resistant Staphylococcus Aureus Testing Production Capacity, Revenue, Price and Gross Margin
5.9 Eurofins
5.9.1 Eurofins Company Profile
5.9.2 Eurofins Methicillin-Resistant Staphylococcus Aureus Testing Product Specification
5.9.3 Eurofins Methicillin-Resistant Staphylococcus Aureus Testing Production Capacity, Revenue, Price and Gross Margin
5.10 Puritan Medical
5.10.1 Puritan Medical Company Profile
5.10.2 Puritan Medical Methicillin-Resistant Staphylococcus Aureus Testing Product Specification
5.10.3 Puritan Medical Methicillin-Resistant Staphylococcus Aureus Testing Production Capacity, Revenue, Price and Gross Margin
5.11 Arlington Scientific
5.11.1 Arlington Scientific Company Profile
5.11.2 Arlington Scientific Methicillin-Resistant Staphylococcus Aureus Testing Product Specification
5.11.3 Arlington Scientific Methicillin-Resistant Staphylococcus Aureus Testing Production Capacity, Revenue, Price and Gross Margin
5.12 Luminex
5.12.1 Luminex Company Profile
5.12.2 Luminex Methicillin-Resistant Staphylococcus Aureus Testing Product Specification
5.12.3 Luminex Methicillin-Resistant Staphylococcus Aureus Testing Production Capacity, Revenue, Price and Gross Margin
6. North America
6.1 North America Methicillin-Resistant Staphylococcus Aureus Testing Market Size
6.2 North America Methicillin-Resistant Staphylococcus Aureus Testing Key Players in North America
6.3 North America Methicillin-Resistant Staphylococcus Aureus Testing Market Size by Type
6.4 North America Methicillin-Resistant Staphylococcus Aureus Testing Market Size by Application
7. East Asia
7.1 East Asia Methicillin-Resistant Staphylococcus Aureus Testing Market Size
7.2 East Asia Methicillin-Resistant Staphylococcus Aureus Testing Key Players in North America
7.3 East Asia Methicillin-Resistant Staphylococcus Aureus Testing Market Size by Type
7.4 East Asia Methicillin-Resistant Staphylococcus Aureus Testing Market Size by Application
8. Europe
8.1 Europe Methicillin-Resistant Staphylococcus Aureus Testing Market Size
8.2 Europe Methicillin-Resistant Staphylococcus Aureus Testing Key Players in North America
8.3 Europe Methicillin-Resistant Staphylococcus Aureus Testing Market Size by Type
8.4 Europe Methicillin-Resistant Staphylococcus Aureus Testing Market Size by Application
9. South Asia
9.1 South Asia Methicillin-Resistant Staphylococcus Aureus Testing Market Size
9.2 South Asia Methicillin-Resistant Staphylococcus Aureus Testing Key Players in North America
9.3 South Asia Methicillin-Resistant Staphylococcus Aureus Testing Market Size by Type
9.4 South Asia Methicillin-Resistant Staphylococcus Aureus Testing Market Size by Application
10. Southeast Asia
10.1 Southeast Asia Methicillin-Resistant Staphylococcus Aureus Testing Market Size
10.2 Southeast Asia Methicillin-Resistant Staphylococcus Aureus Testing Key Players in North America
10.3 Southeast Asia Methicillin-Resistant Staphylococcus Aureus Testing Market Size by Type
10.4 Southeast Asia Methicillin-Resistant Staphylococcus Aureus Testing Market Size by Application
11. Middle East
11.1 Middle East Methicillin-Resistant Staphylococcus Aureus Testing Market Size
11.2 Middle East Methicillin-Resistant Staphylococcus Aureus Testing Key Players in North America
11.3 Middle East Methicillin-Resistant Staphylococcus Aureus Testing Market Size by Type
11.4 Middle East Methicillin-Resistant Staphylococcus Aureus Testing Market Size by Application
12. Africa
12.1 Africa Methicillin-Resistant Staphylococcus Aureus Testing Market Size
12.2 Africa Methicillin-Resistant Staphylococcus Aureus Testing Key Players in North America
12.3 Africa Methicillin-Resistant Staphylococcus Aureus Testing Market Size by Type
12.4 Africa Methicillin-Resistant Staphylococcus Aureus Testing Market Size by Application
13. Oceania
13.1 Oceania Methicillin-Resistant Staphylococcus Aureus Testing Market Size
13.2 Oceania Methicillin-Resistant Staphylococcus Aureus Testing Key Players in North America
13.3 Oceania Methicillin-Resistant Staphylococcus Aureus Testing Market Size by Type
13.4 Oceania Methicillin-Resistant Staphylococcus Aureus Testing Market Size by Application
14. South America
14.1 South America Methicillin-Resistant Staphylococcus Aureus Testing Market Size
14.2 South America Methicillin-Resistant Staphylococcus Aureus Testing Key Players in North America
14.3 South America Methicillin-Resistant Staphylococcus Aureus Testing Market Size by Type
14.4 South America Methicillin-Resistant Staphylococcus Aureus Testing Market Size by Application
15. Rest of the World
15.1 Rest of the World Methicillin-Resistant Staphylococcus Aureus Testing Market Size
15.2 Rest of the World Methicillin-Resistant Staphylococcus Aureus Testing Key Players in North America
15.3 Rest of the World Methicillin-Resistant Staphylococcus Aureus Testing Market Size by Type
15.4 Rest of the World Methicillin-Resistant Staphylococcus Aureus Testing Market Size by Application
16 Methicillin-Resistant Staphylococcus Aureus Testing Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter
Global MRSA Testing Market Segmentation
By Test Method
-
Molecular Diagnostics (PCR-based assays)
-
Immunodiagnostics
-
Culture-Based & Blood Testing
-
Others
By Sample Type
-
Nasal & Skin Swabs
-
Blood Samples
-
Wound & Tissue Samples
By Turnaround Time
-
Rapid / Point-of-Care Tests
-
Laboratory-Based Tests
By Application
-
Hospitals
-
Clinics
-
Diagnostic & Reference Laboratories
-
Long-Term Care & Others
Competitive Landscape – Key Market Players
Competition is driven by test sensitivity, speed, automation compatibility, and regulatory approvals. Key players include:
-
Roche
-
BD
-
Bio-Rad
-
bioMérieux
-
Abbott
-
Danaher
-
Hain Lifescience
-
Abacus Diagnostica
-
Eurofins
-
Luminex
-
Puritan Medical
-
Arlington Scientific
